Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Coronavirus channel feed
Despite FDA go-ahead, Emergent still sits on millions of J&J vaccine doses — report
4 years ago
Manufacturing
Covid-19 manufacturing roundup: Biden pumps $500M into domestic testing production; Valneva mulls production deal
4 years ago
Manufacturing
Covid-19 roundup: US buys 50M Pfizer pediatric doses; Vir and GSK publish mAb data in NEJM
4 years ago
Cheap SSRI drug proves successful in reducing Covid-related hospitalization times in large trial
4 years ago
R&D
Novavax takes protein-based Covid-19 vaccine overseas, asking for an approval in the UK
4 years ago
FDA didn't conduct any new inspections of Covid-19 vaccine manufacturing facilities prior to issuing EUAs
4 years ago
FDA+
Covid-19 roundup: Merck shares molnupiravir with a UN-backed nonprofit; GSK halts Covid-19 research on monoclonal antibody
4 years ago
FDA's vaccine adcomm votes almost unanimously in favor of Pfizer's Covid-19 vaccine for younger children
4 years ago
FDA+
FDA shuts down anti-vax lawyer's petition to end Moderna and J&J EUAs
4 years ago
Covid-19 roundup: Moderna says vaccine produces 'strong' response in 5- to 11-year-olds; Aspen Pharmacare plans to up vaccine production in South Africa — report
4 years ago
FDA says benefits of Covid-19 vaccine for younger children outweigh risks
4 years ago
FDA+
Covid-19 roundup: White House pushes for IP waiver support to WTO; Rare nerve disorder listed as AstraZeneca side effect in UK
4 years ago
Covid-19 roundup: Pfizer/BioNTech say booster is 95.6% effective; European Parliament calls for more vaccine transparency
4 years ago
Booster bonanza: FDA endorses 'mix-and-match' scheme, and Moderna and J&J too
4 years ago
Covid-19 roundup: Biden plans for early November rollout of vaccines for kids; EMA evaluates Regeneron's antibody combo
4 years ago
Manufacturing woes for Novavax’s Covid jab badly disrupt plans for rollout to the poor — report
4 years ago
Manufacturing
Gates Foundation pledges $120M to ramp up generic supply of Merck's Covid-19 pill while activists blast Pfizer's disproportionate power
4 years ago
Roche-Atea’s Covid-19 pill fails mid-stage trial, clouding future for closely watched program
4 years ago
R&D
Covid-19 roundup: FDA to give OK for mix-and-match booster shots — report; WHO group leads campaign to acquire antiviral drugs for $10
4 years ago
Small biotech says its Covid-19 vaccine spurs more antibodies than AstraZeneca’s. Will supply deals come now?
4 years ago
R&D
Q&A: Tillman Gerngross explains why his Covid mAb will have an edge over an already crowded field
4 years ago
Bayer breaks off Covid-19 vaccine manufacturing pact as CureVac pivots to second-gen work — report
4 years ago
Manufacturing
FDA's vaccine adcomm unanimously supports Moderna's booster in same populations as Pfizer's booster
4 years ago
FDA+
Covid-19 roundup: Regeneron nabs priority review for mAb; Preprint suggests mixing boosters is safe ahead of adcomms
4 years ago
First page
Previous page
18
19
20
21
22
23
24
Next page
Last page